Pfizer, Merck trial antiviral combos amid concerns over resistance to COVID-19 pills
Summary by Ground News
1 Articles
1 Articles
Pfizer, Merck trial antiviral combos amid concerns over resistance to COVID-19 pills
Pfizer (PFE) and Merck (MRK), the developers of the first oral medications for COVID-19 in the U.S., are advancing combination studies for their antiviral therapies as experts flag the...
·United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium